Search for: "Novartis Pharmaceuticals Corporation" Results 121 - 140 of 155
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Sep 2010, 12:39 pm by FDABlog HPM
Karst –    On September 22, 2010, Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
25 Aug 2010, 7:37 am by Levin & Perconti
The drug is manufactured by Finnish drugmaker Orion Corporation and is marked by Swiss-based Novartis Pharmaceuticals. [read post]
30 Jul 2010, 4:06 am by Andrew Frisch
Alpharma notes that from the beginning of their employment, Alpharma PSRs receive training and instruction from Alpharma specifically designed to ensure the Alpharma Representatives did not deviate from corporate-approved messages about the drugs. [read post]
19 Jul 2010, 7:07 pm by Piper Hoffman
The latest example is Novartis, a pharmaceutical company, which settled a gender discrimination class action for up to $175 million last week. [read post]
7 Jul 2010, 8:45 am
On July 6, 2010, the United States Court of Appeals for the Second Circuit, which sits in New York City, ruled against Novartis Pharmaceuticals Corporation ("Novartis") on claims brought by current and former pharmaceutical representatives for overtime pay. [read post]
17 Jun 2010, 6:47 am by Andrew Frisch
In its brief, the DOL argues that the district court in that case committed legal error when it concluded that the pharmaceutical sales representatives employed by Novartis Pharmaceutical Corporation (“NPC”) were exempt from the overtime requirements of the FLSA under the outsides sales and administrative exemptions. [read post]
8 Jun 2010, 1:58 pm by Matthew Kadushin
Swiss pharmaceutical firm Novartis was found guilty of New York sexual harassment and discrimination last Monday by a jury and ordered to pay out $3.3 million to a dozen women who headed up a class action suit. [read post]
2 Jun 2010, 8:50 am
Department of Energy 82 Teach for America 83 Abbott 84 AT&T 85 MGM Mirage 86 Mayo Clinic 87 Lockheed Martin Corporation 88 Merck 89 Limited Brands 90 Hyatt Hotels and Resorts 91 Colgate-Palmolive Company 92 Dell Inc. 93 Lilly 94 Novartis Pharmaceuticals Corporation 95 The Vanguard Group 96 Oracle 97 Vestas 98 Wal-Mart Stores Inc. 99 Honda Companies 100 [read post]
5 May 2010, 5:14 pm by FDABlog HPM
Martin – FDA just released the Warning Letter it issued to Novartis Pharmaceuticals Corporation (“Novartis”) in April regarding two purportedly unbranded websites, and (the “alliance websites”), which included disease-state information and clinical data about gastrointestinal stromal tumors (“GIST”) and chronic myeloid leukemia (“CML”).  [read post]
4 May 2010, 10:29 pm by Ben Vernia
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
2 Mar 2010, 6:28 am by John J. Cord
Up until now, online social networking has been treated mostly as a plaything for some pharmaceutical manufacturers. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
19 Oct 2009, 1:24 am
The ruling wipes out verdicts of $33 million against Novartis, $81 million against GlaxoSmithKline, and $215 million (reduced post-trial to $160 million) against AstraZeneca. [read post]
30 Aug 2009, 10:00 pm
Bivins (a citizen of Texas) sued Novartis Pharmaceuticals (a Delaware corporation with its principal place of business in New Jersey), Novartis Pharma GmbH (a German corporation), and Novartis AG (a Swiss corporation) in New Jersey state court. [read post]
2 Feb 2009, 9:51 am
This January 2008 press release from KV Pharmaceutical, the parent company of ETHEX, includes a list of the more than 60 generic drugs being recalled by ETHEX. [read post]